Partial deletion of the short arm of chromosome 3 syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:261875
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Partial deletion of the short arm of chromosome 3 syndrome (also known as 3p deletion syndrome or 3p- syndrome) is a rare chromosomal disorder caused by the loss of genetic material from the short arm (p arm) of chromosome 3. The size and exact location of the deleted segment can vary among affected individuals, which leads to a wide spectrum of clinical severity. This condition is typically characterized by intellectual disability, developmental delay, growth retardation, and distinctive craniofacial features including microcephaly, ptosis, a broad nasal bridge, micrognathia, and low-set ears. The syndrome affects multiple body systems. Affected individuals may present with congenital heart defects, gastrointestinal anomalies, renal malformations, and skeletal abnormalities. Hypotonia (low muscle tone) is frequently observed in infancy and can contribute to feeding difficulties and delayed motor milestones. Some patients may also experience seizures and vision or hearing problems. Behavioral difficulties, including features overlapping with autism spectrum disorder, have been reported in some cases. There is no cure for 3p deletion syndrome, and management is supportive and symptom-based. Treatment typically involves a multidisciplinary approach including early intervention programs, speech and occupational therapy, physical therapy, and specialized educational support. Cardiac, renal, or other structural anomalies may require surgical correction. Regular developmental assessments and monitoring by relevant specialists (cardiology, neurology, ophthalmology, audiology) are recommended to optimize outcomes and quality of life.

Also known as:

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Partial deletion of the short arm of chromosome 3 syndrome.

View clinical trials →

No actively recruiting trials found for Partial deletion of the short arm of chromosome 3 syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Partial deletion of the short arm of chromosome 3 syndrome community →

No specialists are currently listed for Partial deletion of the short arm of chromosome 3 syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Partial deletion of the short arm of chromosome 3 syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Partial deletion of the short arm of chromosome 3 syndromeForum →

No community posts yet. Be the first to share your experience with Partial deletion of the short arm of chromosome 3 syndrome.

Start the conversation →

Latest news about Partial deletion of the short arm of chromosome 3 syndrome

No recent news articles for Partial deletion of the short arm of chromosome 3 syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Partial deletion of the short arm of chromosome 3 syndrome

What is Partial deletion of the short arm of chromosome 3 syndrome?

Partial deletion of the short arm of chromosome 3 syndrome (also known as 3p deletion syndrome or 3p- syndrome) is a rare chromosomal disorder caused by the loss of genetic material from the short arm (p arm) of chromosome 3. The size and exact location of the deleted segment can vary among affected individuals, which leads to a wide spectrum of clinical severity. This condition is typically characterized by intellectual disability, developmental delay, growth retardation, and distinctive craniofacial features including microcephaly, ptosis, a broad nasal bridge, micrognathia, and low-set ears

At what age does Partial deletion of the short arm of chromosome 3 syndrome typically begin?

Typical onset of Partial deletion of the short arm of chromosome 3 syndrome is neonatal. Age of onset can vary across affected individuals.